Alexander V Kabanov Selected Research

Therapeutic Uses

3/2021	Preparation of an Orthotopic, Syngeneic Model of Lung Adenocarcinoma and the Testing of the Antitumor Efficacy of Poly(2-oxazoline) Formulation of Chemo-and Immunotherapeutic Agents.
10/2017	Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity.
11/2013	Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander V Kabanov Research Topics

Disease

51	Neoplasms (Cancer) 03/2024 - 08/2002
13	Parkinson Disease (Parkinson's Disease) 03/2022 - 09/2007
11	Inflammation (Inflammations) 04/2021 - 12/2006
10	Breast Neoplasms (Breast Cancer) 04/2023 - 01/2005
8	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 08/2011
7	Obesity 12/2022 - 04/2010
6	Triple Negative Breast Neoplasms 03/2024 - 01/2020
6	Carcinoma (Carcinomatosis) 07/2019 - 08/2006
4	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2015
4	Infections 01/2022 - 03/2011
4	Neuroinflammatory Diseases 12/2019 - 09/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2015 - 01/2004
3	Neoplasm Metastasis (Metastasis) 08/2023 - 01/2018
3	Encephalitis (Encephalitis, Rasmussen) 12/2019 - 05/2007
3	Disease Progression 01/2019 - 04/2010
3	Glioma (Gliomas) 11/2016 - 05/2015
2	Medulloblastoma 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Edema (Dropsy) 04/2021 - 01/2015
2	Uveitis 04/2021 - 01/2015
2	Hyperemia 04/2021 - 01/2015
2	Adenocarcinoma of Lung 03/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 10/2017 - 09/2014
2	Ischemia 06/2016 - 01/2016
2	Hyperthermia 12/2015 - 04/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2014 - 08/2010
2	Hypertension (High Blood Pressure) 08/2014 - 08/2010
2	Heart Failure 08/2014 - 08/2010
2	Adenocarcinoma 01/2013 - 10/2009
2	Leukemia 01/2013 - 11/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2023
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Blindness (Hysterical Blindness) 04/2021
1	Eye Diseases (Eye Disease) 04/2021

Drug/Important Bio-Agent (IBA)

22	Poloxamer (Poloxamer 407)IBA 04/2022 - 08/2002
18	MicellesIBA 08/2023 - 12/2004
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 08/2003
11	Proteins (Proteins, Gene)FDA Link 06/2023 - 10/2006
10	Paclitaxel (Taxol)FDA LinkGeneric 08/2023 - 08/2014
10	EnzymesIBA 04/2021 - 08/2010
9	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 08/2006
9	AntioxidantsIBA 04/2021 - 09/2007
9	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 08/2002
8	PolymersIBA 11/2013 - 03/2006
7	CatalaseIBA 09/2017 - 01/2011
6	NanogelsIBA 05/2015 - 09/2005
5	LeptinIBA 12/2022 - 04/2010
4	Neuroprotective AgentsIBA 03/2022 - 01/2014
4	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 03/2022 - 01/2014
4	poly(2-oxazoline)IBA 03/2021 - 01/2019
4	CopperIBA 01/2019 - 08/2014
4	ZincIBA 01/2019 - 08/2014
4	Superoxide DismutaseIBA 01/2019 - 08/2014
4	polyethylene glycol polyethyleneimine nanogelIBA 05/2015 - 09/2005
3	Ferrosoferric Oxide (Magnetite)FDA Link 01/2022 - 05/2016
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2021 - 10/2013
3	Superoxide Dismutase-1IBA 04/2021 - 08/2010
3	Therapeutic UsesIBA 03/2021 - 11/2013
3	SP 1049CIBA 01/2020 - 11/2008
3	PlatinumIBA 01/2020 - 11/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 03/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2014 - 09/2002
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2013 - 09/2005
3	Ethylene Oxide (Oxirane)IBA 05/2010 - 01/2005
2	remdesivirIBA 01/2022 - 01/2021
2	FibrinIBA 04/2021 - 01/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2019 - 05/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2018 - 11/2016
2	Drug CombinationsIBA 01/2018 - 11/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 05/2015
2	Liposomes (Liposome)IBA 11/2016 - 05/2013
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 05/2016 - 10/2013
2	Monoclonal AntibodiesIBA 05/2015 - 05/2015
2	Superoxides (Superoxide)IBA 08/2014 - 08/2010
2	Angiotensin IIIBA 08/2014 - 08/2010
2	methacrylic acidIBA 01/2012 - 02/2010
2	polypropylene glycol (poly(propylene oxide))IBA 05/2010 - 01/2005
2	Adenosine Triphosphate (ATP)IBA 05/2010 - 08/2003
2	Surface-Active Agents (Surfactants)IBA 11/2008 - 12/2004
2	AnthracyclinesIBA 08/2003 - 09/2002
1	pexidartinibIBA 08/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2023
1	palbociclibIBA 01/2022
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	sapanisertibIBA 01/2022
1	AerosolsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	triphosphoric acid (triphosphate)IBA 01/2021

Therapy/Procedure

26	Therapeutics 03/2024 - 05/2007
15	Drug Therapy (Chemotherapy) 06/2023 - 08/2003
2	Precision Medicine 01/2022 - 05/2016
2	Art Therapy 03/2011 - 05/2007
1	Radiotherapy 03/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2023
1	Intravenous Injections 03/2021